Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s487496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Xiaoxu Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Isoflavones, Janus Kinase 2, STAT3 Transcription Factor, Ferroptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- School of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, People's Republic of China.
ORCID-Profile: Xiaoxu Fan
Zitieren
APA
Fan, X., Liu, S., Yu, J., Hua, J., Feng, Y., Wang, Z., Shen, Y., Lan, W., & Wang, J. (2025). Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s487496
Vancouver
Fan X, Liu S, Yu J, Hua J, Feng Y, Wang Z, et al. Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s487496
BibTeX
@article{Fan2025,
author = {Fan, Xiaoxu and Liu, Shuangqiao and Yu, Jing and Hua, Jian and Feng, Yingtong and Wang, Zhen and Shen, Yiwei and Lan, Wei and Wang, Jingxia},
title = {Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s487496}
}
EUVIMED